Drug Shortage Report for MIDAZOLAM INJECTION
| Report ID | 158768 |
| Drug Identification Number | 02242904 |
| Brand name | MIDAZOLAM INJECTION |
| Common or Proper name | Midazolam Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | MIDAZOLAM |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10mL |
| ATC code | N05CD |
| ATC description | HYPNOTICS AND SEDATIVES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-02-02 |
| Estimated end date | Unknown |
| Actual end date | 2022-07-31 |
| Shortage status | Resolved |
| Updated date | 2022-08-04 |
| Company comments | On 100% allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-08-04 | French | Compare |
| v3 | 2022-08-04 | English | Compare |
| v2 | 2022-04-13 | French | Compare |
| v1 | 2022-04-13 | English | Compare |
Showing 1 to 4 of 4